Nancy F. Crum-Cianflone
Research Subjects
Nancy F. Crum-Cianflone has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
April Truett
Infectious Diseases Clinic, Naval Medical Center San Diego, San Diego, California
1 shared publicationBraden Hale
Infectious Diseases Clinic, Naval Medical Center San Diego, San Diego, California
1 shared publicationBrandie Pope
Tri-Service AIDS Clinical Consortium, Rockville, Maryland
1 shared publicationCarolyn Brandt
Tri-Service AIDS Clinical Consortium, Rockville, Maryland
1 shared publicationChristopher Amling
Urology Department, Naval Medical Center San Diego, San Diego, California
1 shared publicationKari Furtek
Tri-Service AIDS Clinical Consortium, Rockville, Maryland
1 shared publication
Latest Publications
- 1 January 2007
- Published by SAGE Publications in AIDS Patient Care and STDs
- Vol. 21 (1) , 9-19
Erectile Dysfunction and Hypogonadism among Men with HIV
Erectile dysfunction (ED) and hypogonadism are increasingly recognized conditions, however, the prevalence and etiologies of these conditions among HIV-infected men remain unclear. We studied 300 HIV-infected men who completed standardized questionnaires regarding sexual function and hypogonadal symptoms. An early morning testosterone test was performed; patients with a low serum testosterone level (defined by 3 (range, 1–1531). Sixty percent were receiving antiretroviral therapy. ED was reported by 61.4%; of those with ED, 32% did not have a rigid enough erection for penetration, and 46% were unable to sustain an erection for the completion of intercourse. In the multivariate analysis, increasing age (odds ratio [OR] 1.4 for a 5-year increment, p < 0.001) and depression (OR 2.64, p < 0.0001) were associated with ED. A higher current CD4 count was protective (OR 0.80 for each 100 cells/mm3, p = 0.004). Only 25% of patients with ED had utilized a phosphodiesterase-5-inhibitor for treatment. Seventeen percent of the 300 men were hypogonadal; there was no correlation between hypogonadism and ED. Increasing age and a higher body mass index (BMI) were positively associated with hypogonadism, while smoking was negatively associated (OR 0.44, p = 0.02). All patients with low testosterone had secondary hypogonadism. There was no association between ED or hypogonadism with the current, past, or cumulative use of HIV medications.
- 1 January 2007
- Published by SAGE Publications in AIDS Patient Care and STDs
- Vol. 21 (1) , 9-19
Erectile Dysfunction and Hypogonadism among Men with HIV
Erectile dysfunction (ED) and hypogonadism are increasingly recognized conditions, however, the prevalence and etiologies of these conditions among HIV-infected men remain unclear. We studied 300 HIV-infected men who completed standardized questionnaires regarding sexual function and hypogonadal symptoms. An early morning testosterone test was performed; patients with a low serum testosterone level (defined by 3 (range, 1–1531). Sixty percent were receiving antiretroviral therapy. ED was reported by 61.4%; of those with ED, 32% did not have a rigid enough erection for penetration, and 46% were unable to sustain an erection for the completion of intercourse. In the multivariate analysis, increasing age (odds ratio [OR] 1.4 for a 5-year increment, p < 0.001) and depression (OR 2.64, p < 0.0001) were associated with ED. A higher current CD4 count was protective (OR 0.80 for each 100 cells/mm3, p = 0.004). Only 25% of patients with ED had utilized a phosphodiesterase-5-inhibitor for treatment. Seventeen percent of the 300 men were hypogonadal; there was no correlation between hypogonadism and ED. Increasing age and a higher body mass index (BMI) were positively associated with hypogonadism, while smoking was negatively associated (OR 0.44, p = 0.02). All patients with low testosterone had secondary hypogonadism. There was no association between ED or hypogonadism with the current, past, or cumulative use of HIV medications.